Delhi High Court - Orders
2136 cases · page 31 of 72
Showing 901–929Nymox Corporation v.Assistant Controller Of Patents And Design
Nymox Corporation filed an appeal challenging the order passed by the Assistant Controller of Patents and Designs rejecting its patent application. The rejection was based on grounds related to novelty, inventive step, and subject matter limitations under the Patents Act, 1970.
Eveready Industries India Limited v.Ksc Industries & Ors.
The Delhi High Court granted an interim injunction in favor of Eveready Industries India Limited against Ksc Industries & Ors. The court found that the Defendants' use of the mark 'EVERYDAY' was deceptively similar to Eveready's well-known trademark, 'EVEREADY', leading to potential infringement and passing off. Given the prima facie case made out by Eveready and the risk of irreparable harm, the court restrained the defendants from manufacturing or selling goods under the impugned mark until further hearing.
L Oreal v.The Assistant Controller Of Patents And Designs
L Oreal appealed an order by the Assistant Controller of Patents which rejected its patent application (No. 4652/DELNP/2013) for a process using thiopyridinone compounds. The appellant argued that the rejection was arbitrary, lacked reasoning, and failed to consider expert reports or properly analyze prior art under the Patents Act, 1970.
Ceat Limited v.The Registrar Of Trade Marks
The Delhi High Court dismissed Ceat Limited's appeal challenging the rejection of its trademark application 'FARMAX'. The court found that the appellant failed to adequately explain a significant delay in filing the appeal, rendering the condonation plea specious. Furthermore, on the merits, the court held that 'FARMAX' was structurally and phonetically similar to existing marks ('FORMAX' and 'FARMOX') registered for related goods (vehicles/tractors), creating a strong likelihood of consumer confusion.
Puma Se v.Gajari Online Services Private Limited
The Delhi High Court granted a rectification petition filed by Puma Se against Gajari Online Services Private Limited, ordering the variation of the respondent's registered trademark (No. 3685326). The court accepted the petitioner's argument that the 'leaping lion' device within the impugned mark was deceptively similar to Puma's well-known 'leaping cat' device. Consequently, the court directed the deletion of the leaping lion element from the trademark while allowing the word 'GAJARI' to remain.
Mankind Pharma Limited v.Passiflora Pharmaceuticals
Mankind Pharma Limited filed a suit seeking permanent injunction against Passiflora Pharmaceuticals, alleging trademark infringement of its registered mark 'FLORA' in the pharmaceutical sector. The court addressed several interlocutory applications, including granting exemption from pre-institution mediation and setting timelines for filing replies to the injunction application (Order XXXIX Rule 1 & 2 CPC). The proceedings are moving forward with standard civil procedure steps, indicating an active dispute over brand reputation and market goodwill.
Everest Food Products Private Limited v.Everest Beverages And Food Industries & Anr.
This appeal before the Delhi High Court challenges an earlier order that set aside an opposition filed by Everest Food Products against a Trademark Application. The appellant argued that crucial documents were misplaced or not supplied to them, hindering their ability to present a full case regarding prior use and rights. While the court did not rule on the merits of the trademark dispute, it granted an adjournment to allow further submissions and document exchange.
Abhishek Kumar Goyal v.M/S Diyaa Enterprises & Anr.
The Delhi High Court allowed an appeal filed by the appellant against a Hearing Officer's decision in a trademark opposition case concerning detergent products. The court found that the original officer erred by comparing the respondent's mark with only the appellant's word mark, ignoring the appellant's prior device mark which was on record and presented during hearings. Consequently, the High Court set aside the impugned order and remanded the matter back to the Registrar of Trade Marks for a fresh, de novo hearing.
Pfizer Inc. v.Incepta Pharmaceuticals Limited
The court confirmed an ex-parte ad-interim injunction granted earlier, restricting defendants from dealing in infringing products related to Patents No. 243571 and 250050, as other patents had expired. The court also directed service of notice for discovery regarding the origin and import of impugned products and allowed amendments to the plaint.
Suzuki Motor Corporation v.Controller General Of Patents, Designs and Trademarks And Anr
Suzuki Motor Corporation appealed regarding objections related to their patent claims. The Court noted that while there is no specific provision for re-consideration, amendments might be allowed if errors relate to translation/transliteration. The Court subsequently directed the Appellant to file an application under Section 57 of the Patents Act to amend their modified claims.
Baxalta Incorporated v.The Controller Of Patents
Baxalta Incorporated appealed a decision by the Assistant Controller of Patents which refused their application for "FACTOR VIII POLYMER CONJUGATES" due to lack of novelty and inventive steps in product claims. The appellant sought leave to submit an auxiliary claim set restricting the scope to method claims. The High Court allowed this submission, setting aside the impugned order and remanding the matter for fresh consideration.
M/S Imberatek Llc v.Apple Inc & Anr.
M/S Imberatek Llc filed a commercial suit alleging patent infringement against Apple Inc. Initially, the plaintiff sought to withdraw the suit to explore mediation, and the court allowed it with a refund of court fees. However, subsequent consideration found that since no urgent interim relief was sought, the plaintiff could not circumvent the mandatory requirement of pre-litigation mediation under Section 12A of the Commercial Courts Act, leading to the final dismissal of the suit.
Pawan Kumar Goel v.Dr. Dhan Singh & Anr.
The plaintiff filed a suit claiming infringement of Patent 369150, which covers a novel process for extracting Alpha Yohimbine. The plaintiff sought an interim injunction to stop the defendants from using or manufacturing the subject compound. However, the court noted evidence presented by the defendants showing they were already manufacturing the compound through a similar process prior to the patent application date.
Saera Electric Auto Limited v.Malak Techno Private Limited
Saera Electric Auto Limited successfully resolved its trademark infringement suit against Malak Techno Private Limited through mediation. The parties entered into a comprehensive settlement agreement, which the Delhi High Court subsequently decreed. Under the terms, Malak Techno agreed to cease all use of the impugned mark 'MAYUR' and any deceptively similar variations, acknowledge Saera as the sole owner of the 'MAYURI' trademarks and copyright in its logo, and pay damages totaling Rs. 2,50,000/-.
Sunil Dutt Trading As Kilter v.Pro Muscle Science & Anr.
The Delhi High Court addressed the dispute between Kilter (owner of 'MUSCLE SCIENCE') and Pro Muscle Science regarding trademark infringement in the dietary supplement market. The court found that the Defendants' use of marks like 'PRO MUSCLE SCIENCE' was highly likely to cause consumer confusion, as the Plaintiff's registered mark is entirely incorporated into the competing names. Consequently, the existing interim injunction favoring the Plaintiff was confirmed. While the matter proceeds toward mediation, the ruling strongly affirms the protection afforded to established trademarks against similar competitors.
Sequoia Capital Operations Llc & Ors v.John Doe And Others
In this trademark infringement suit, the Delhi High Court addressed an application seeking to involve WhatsApp LLC in the proceedings. The court allowed WhatsApp's impleadment and issued specific directions requiring the platform to remove or block identified infringing groups and accounts associated with Sequoia Capital's trademarks. Crucially, while ordering the removal of known infringers, the court also mandated that Plaintiffs must first notify account holders before any further blocking action is taken, balancing enforcement needs with due process concerns.
Ab Initio Technology Llc v.Assistant Controller Of Patents And Designs / The Controller of Patents
Ab Initio Technology Llc appealed against an order rejecting its patent application. The core dispute revolves around whether the claimed method for data processing qualifies as an invention despite being classified as a computer program per se under Section 3(k) of the Patents Act, 1970.
Niranjan Arvind Gosavi And Ors v.Innovatiview India Private Limited
The plaintiffs filed a commercial suit alleging that the defendant infringed their patent (No. 336205) related to secure document validation methods by bidding for an NTA e-tender requiring enhanced QR Code solutions. The court refused to grant an ad-interim injunction, considering the impact on the tendering process, but directed the defendant to maintain full accounts if they succeed in the tender.
F- Hoffmann -La Roche Ag v.Zydus Lifesciences Limited
The Plaintiffs (F- Hoffmann -La Roche Ag) filed an application seeking the constitution of a Confidentiality Club. The Defendant (Zydus Lifesciences Limited) argued that access should be contingent upon preliminary findings regarding the identity of the biosimilar to the innovator drug. The Court directed both parties to submit their proposed members for the confidentiality club.
Novartis Ag & Anr. v.Medisave Formulations India Llp
The Delhi High Court granted interim relief in the trademark infringement suit filed by Novartis against Medisave Formulations. Recognizing the urgent nature of the case, the court exempted the plaintiffs from standard procedural requirements like advance service and pre-institution mediation. Crucially, the court appointed a Local Commissioner to conduct a search at the defendant's premises, seize infringing products bearing the mark 'ZYMADA', and inspect relevant financial documents, finding prima facie evidence of deceptive similarity between the marks and packaging.
Joy Creators Llp v.Bath And Body Works Brands Management Inc.
The Delhi High Court directed both parties to engage in mandatory pre-litigation mediation regarding a trademark infringement dispute concerning the use of 'JOY'. The plaintiff sought an injunction against Bath & Body Works for alleged passing off and trademark infringement. However, the court noted that the defendants had previously proposed a resolution, suggesting they would only sell the product through their own branded stores to avoid confusion, and were willing to refrain from filing trademarks on 'JOY' as a descriptive term. Given these discussions, the Court mandated mediation to explore an amicable settlement before proceeding with litigation.
Crystal Crop Protection Limited v.Safex Chemicals India Limited & Ors
The Plaintiff alleges that the Defendants' product composition infringes on their patented weedicidal formulation, which includes a specific blend of chemicals. The case involves determining whether the Defendants' product violates the claims of the Plaintiff's patent.
Eli Lilly And Company Private Limited v.Eskayef Pharmaceuticals Limited
Plaintiffs, Eli Lilly And Company, filed a suit alleging infringement of their Indian Patent No. IN 297760 (covering Abemaciclib) by the Impugned Drug 'Abeclib', manufactured by Defendant No. 1. The court prima facie found that 'Abeclib' infringes the patent and granted an interim injunction.
Wyeth Llc v.The Controllers Of Patents
Wyeth LLC appealed an impugned order regarding its patent application. The core dispute revolves around amendments made by the appellant from a PCT application (claiming a 'regimen') to subsequent national phase applications (claiming a 'combination' and 'pharmaceutical pack'). Wyeth argues these amendments were within the scope of Section 59 of the Patents Act, 1970.
Novartis Ag & Ors. v.Noviets Pharma & Ors.
The Delhi High Court addressed several interlocutory applications in the trademark infringement dispute between Novartis Ag & Ors. and Noviets Pharma & Ors. The court allowed the plaintiffs to file additional documents and granted an exemption from mandatory pre-suit mediation. Crucially, the court formally registered the plaint as a suit, setting out detailed procedural timelines for filing written statements, replications, and affidavits of admission/denial, while also addressing the preliminary injunction application seeking restraint against trademark infringement.
Pfizer Inc. v.Beacon Pharmaceuticals Limited
The case involves a patent infringement dispute where Pfizer Inc. claims that Beacon Pharmaceuticals has infringed on their patents. An ex-parte ad-interim injunction was granted in favor of the Plaintiffs regarding the subsisting patents.
Kao Corporation v.The Controller Of Patents & Anr.
Kao Corporation appealed a rejection order issued by the Controller of Patents concerning its patent application No. 5945/DELNP/2009. The appellant argued that the Controller's observation contradicted previous hearing notices and written submissions, specifically regarding industrial applicability under Section 2(1)(ac) of the Patents Act, 1970.
Bdr Pharmaceuticals International Pvt Ltd v.Kudos Pharmaceuticals Limited & Anr
This order addresses an interim injunction application filed by Kudos Pharmaceuticals Limited (Plaintiff) against Bdr Pharmaceuticals International Pvt Ltd (Defendant). The court noted that the suit patent IN'720 was nearing its expiration date. The parties debated whether to proceed with the hearing given the imminent expiry and broader legal questions regarding patent coverage versus disclosure.
Intellectual Property Attorneys Association (IPAA) v.The Controller General of Patents, Designs & Trade Marks & Anr.
The Intellectual Property Attorneys Association (IPAA) approached the Delhi High Court seeking directions to suspend limitation periods under the Trade Marks Act, citing severe disruptions in accessing the Trademark Registry's online portal. The petitioner highlighted persistent technical difficulties, including non-functional e-filing services and payment gateway issues, which were causing stakeholders to lose valuable IP rights. The Court acknowledged the urgency of the matter, directing the Controller General of Patents, Designs & Trade Marks (CGPDTM) to appear on the next date to provide detailed solutions and status updates regarding the systemic failures.
Kudos Pharmaceuticals Limited v.Natco Pharma Limited
This order addresses an application seeking five corrections to a previous judgment dated March 1, 2024. The plaintiffs sought corrections primarily regarding the timeline of Natco's revocation filing relative to Kudos' infringement suit, and technical errors in referencing patent numbers and claim descriptions.
Facing a similar IP matter?
Arctic Invent is a specialist IP firm with deep litigation expertise across India, EU, US, and UK. Our team uses data-driven strategy to build stronger cases.